Topic: ENT

Aerin Medical today touted one-year results from a trial evaluating the safety and efficacy of its […]

Investors had long expected Intersect ENT to be an acquisition target before Medtronic announced its plans to buy the company last week. Better reimbursement for Intersect ENT’s products and elective procedures returning over the summer months might have helped the deal cross the finish line. 

Medtronic (NYSE:MDT) today announced that it has entered a definitive agreement to acquire Intersect ENT (NSDQ:XENT) for $1.1 […]

Intersect ENT today announced that it has commercially launched its VenSure balloon sinus dilation system […]

Intersect ENT today announced that it has launched its Straight Delivery System with its Propel […]

SafKan Health, a firm based in Tucson, Arizona, won FDA clearance and is about to […]

Intersect ENT (NSDQ:XENT) this week announced it appointed Patrick Broderick as executive VP, general counsel and […]

Hearing device developer Eargo announced today that it priced its initial public offering of common stock at […]

Middle ear imaging technology developer PhotoniCare today filed an SEC Form D to confirm the sale of […]

Critical care facilities around the world are on the front lines of the ongoing COVID-19 […]

Dive Brief: Bloomberg reported late Tuesday that Medtronic made an offer to acquire Intersect ENT, […]

Preceptis Medical today announced FDA clearance that allows placement of its Hummingbird tympanostomy tube system in […]

3NT Medical, a company based in Israel, has won FDA clearance to introduce its Colibri […]

All sorts of medical procedures have to wait to be performed due to the ongoing […]

OtoNexus Medical Technologies filed an amendment to its SEC Form D last week to confirm the […]

Startup Dianosic (Strasbourg, France)  announced today that it has obtained the CE Mark for CAVI-T, a low-pressure […]

San Francisco-based Tivic Health announced that the company has received CE Mark approval in Europe for ClearUP […]

Aerin Medical, based in Austin, Texas, announced this week FDA clearance and US launch of […]